International Experience and Implications of Real-World Evidence Supporting Drug Medical Insurance Access
Objective:This study investigates the application of real-world evidence(RWE)in decision-making of drug medical insurance access in major countries,in order to provide evidence and support for the dynamic adjustment of the China's national medical insurance drug catalog.Methods:A comprehensive literature review was conducted to systematically summarize the current experience of RWE in supporting drug access decision-making in major countries,including the United Kingdom,France,Germany,Italy,Australia,the United States,and Canada.Results:This study focuses on summarizing the application scenarios and specific practice of RWE in drug medical insurance access decision-making in major countries.Based on China's practice,relevant suggestions are proposed for RWE to support the adjustment of national medical insurance drug catalog.Conclusions:RWE plays an increasingly important role in drug medical insurance access decision-making.By considering China's national conditions and practical experience,and drawing upon the experience of major countries,a scientific pathway for RWE to support drug medical insurance access decision-making with Chinese characteristics should be explored.
NETL
NSTL
万方数据
